Combined rotational excimer lASER coronary atherectomy (RASER) in non-crossable, non-dilatable coronary artery disease: Observations from a single center

CONCLUSIONS: In our retrospective, single-center study, patients with CAD who were deemed appropriate for RASER PCI had a high peri-procedural mortality rate. In this context, adjunctive RASER therapy provides acceptable safety and efficacy as a bailout strategy, with at least 3 out of 5 patients achieving satisfactory procedural and angiographic results. Randomized controlled trials are needed to comprehensively compare the clinical outcomes of high-risk RASER PCI vs conservative medical therapy.PMID:38377536 | DOI:10.25270/jic/23.00267
Source: The Journal of Invasive Cardiology - Category: Cardiology Authors: Source Type: research